However, semaglutide produces greater total weight loss over time, averaging 14.9% versus phentermine 5 to 10%
Xin M, Jin X, Cui X, Jin C, Piao L, Wan Y, Xu S, Zhang S, Yue X, Wang H, Nan Y, Cheng X
They could not determine whether obesity lowers B12 levels or if low B12 levels predispose someone to obesity
Possible Side Effects 5-Amino-1MQ has been explored in laboratory and experimental research settings, and observations in some research contexts have included: Injection-site irritation or discomfort Temporary redness or swelling Headaches Nausea Fatigue or temporary energy-related variability Restlessness or stimulation-related observations Appetite-related changes Gastrointestinal discomfort Responses and tolerability observations may vary depending on: Experimental conditions Dosage ranges Protocol duration Administration frequency Concurrent compounds Individual sensitivity Higher-frequency or higher-range experimental protocols may increase the likelihood of tolerability-related observations in some research models